Coppell Advisory Solutions LLC
Position in PRTA — Prothena Corp Public Ltd Co
CIK 1848433
COPPELL, TX
Position in PRTA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$116
New position
Shares Held
12
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#179
of 187 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Coppell Advisory Solutions LLC holds $1,491,155 across 13 Biotechnology names. PRTA ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
12,304 | $698,990 | |
| 2 | ANAB |
Anaptysbio, Inc
|
3,638 | $245,565 | |
| 3 | INCY |
Incyte Corp
|
2,057 | $233,181 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
436 | $216,573 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
962 | $83,645 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
670 | $5,607 | |
| 7 | NTLA |
Intellia Therapeutics, Inc.
|
134 | $2,267 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
59 | $2,189 |
All Filings in PRTA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116 | 12 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||